BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugarbaker PH. Peritonectomy procedures. Surg Oncol Clin N Am. 2003;12:703-727, xiii. [PMID: 14567026 DOI: 10.1016/s1055-3207(03)00048-6] [Cited by in Crossref: 117] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Bijelic L, Kumar AS, Stuart OA, Sugarbaker PH. Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. Gastroenterol Res Pract. 2012;2012:163284. [PMID: 22899903 DOI: 10.1155/2012/163284] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
2 Francescutti V, Rivera L, Seshadri M, Kim M, Haslinger M, Camoriano M, Attwood K, Kane JM 3rd, Skitzki JJ. The benefit of intraperitoneal chemotherapy for the treatment of colorectal carcinomatosis. Oncol Rep 2013;30:35-42. [PMID: 23673557 DOI: 10.3892/or.2013.2473] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
3 Desantis M, Bernard JL, Casanova V, Cegarra-Escolano M, Benizri E, Rahili AM, Benchimol D, Bereder JM. Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg 2015;400:37-48. [PMID: 25319432 DOI: 10.1007/s00423-014-1253-z] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 4.6] [Reference Citation Analysis]
4 Colantonio L, Claroni C, Fabrizi L, Marcelli ME, Sofra M, Giannarelli D, Garofalo A, Forastiere E. A randomized trial of goal directed vs. standard fluid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Gastrointest Surg 2015;19:722-9. [PMID: 25595308 DOI: 10.1007/s11605-015-2743-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
5 Kireeva GS, Bespalov VG, Belyaeva OA, Senchik KY, Stukov AN, Gafton GI, Guseynov KD, Belyaev AM. Normothermic and Hyperthermic Intraperitoneal Chemoperfusions with Cisplatin to Treat Advanced Ovarian Cancer in Experimental Settings. Pathol Oncol Res 2017;23:459-60. [PMID: 28116562 DOI: 10.1007/s12253-017-0202-x] [Reference Citation Analysis]
6 Hillewaere S, Stessens L, der Speeten KV. An Unusual Case of Peritoneal Carcinomatosis. Case Rep Oncol 2010;3:315-25. [PMID: 21060768 DOI: 10.1159/000320623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Chandrashekhara SH, Triveni GS, Kumar R. Imaging of peritoneal deposits in ovarian cancer: A pictorial review. World J Radiol 2016; 8(5): 513-517 [PMID: 27247717 DOI: 10.4329/wjr.v8.i5.513] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
8 Villa AF, El Balkhi S, Aboura R, Sageot H, Hasni-Pichard H, Pocard M, Elias D, Joly N, Payen D, Blot F, Poupon J, Garnier R. Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC). Ind Health 2015;53:28-37. [PMID: 25327298 DOI: 10.2486/indhealth.2014-0025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
9 Rampone B, Schiavone B, Martino A, Confuorto G. Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer. World J Gastroenterol 2010; 16(11): 1299-1302 [PMID: 20238394 DOI: 10.3748/wjg.v16.i11.1299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
10 Mahteme H, Wallin I, Glimelius B, Påhlman L, Ehrsson H. Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion. Eur J Clin Pharmacol 2008;64:907-11. [PMID: 18563401 DOI: 10.1007/s00228-008-0511-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
11 Valle SJ, Alzahrani NA, Liauw W, Sugarbaker PH, Bhatt A, Morris DL. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Methodology, Drugs and Bidirectional Chemotherapy. Indian J Surg Oncol 2016;7:152-9. [PMID: 27065705 DOI: 10.1007/s13193-016-0498-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
12 Terzi C, Arslan NC, Canda AE. Peritoneal carcinomatosis of gastrointestinal tumors: Where are we now? World J Gastroenterol 2014; 20(39): 14371-14380 [PMID: 25339824 DOI: 10.3748/wjg.v20.i39.14371] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
13 Sugarbaker PH. Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? Gastroenterol Res Pract. 2012;2012:309417. [PMID: 22888335 DOI: 10.1155/2012/309417] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
14 Carboni F, Federici O, Zazza S, Corona F, Massimi F, Sperduti I, Valle M. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of non-primary origin. Langenbecks Arch Surg 2021. [PMID: 34686891 DOI: 10.1007/s00423-021-02354-y] [Reference Citation Analysis]
15 Binder S, Lewis AL, Löhr JM, Keese M. Extravascular use of drug-eluting beads: A promising approach in compartment-based tumor therapy. World J Gastroenterol 2013; 19(43): 7586-7593 [PMID: 24282349 DOI: 10.3748/wjg.v19.i43.7586] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Sugarbaker PH, Chang D, Stuart OA. Hyperthermic intraoperative thoracoabdominal chemotherapy. Gastroenterol Res Pract 2012;2012:623417. [PMID: 22654899 DOI: 10.1155/2012/623417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
17 Thorgersen EB, Melum E, Folseraas T, Larsen SG, Line PD. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report. World J Surg Oncol 2018;16:180. [PMID: 30185175 DOI: 10.1186/s12957-018-1482-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Sugarbaker PH, Van der Speeten K, Stuart OA. Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol 2010; 2(1): 19-30 [PMID: 21160813 DOI: 10.4251/wjgo.v2.i1.19] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
19 Sureka B, Meena V, Garg P, Yadav T, Khera PS. Computed tomography imaging of ovarian peritoneal carcinomatosis: a pictorial review. Pol J Radiol 2018;83:e500-9. [PMID: 30655930 DOI: 10.5114/pjr.2018.80247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Näslund Andréasson S, Mahteme H, Sahlberg B, Anundi H. Polycyclic aromatic hydrocarbons in electrocautery smoke during peritonectomy procedures. J Environ Public Health 2012;2012:929053. [PMID: 22685482 DOI: 10.1155/2012/929053] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
21 Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP. Peritoneal carcinomatosis of colorectal origin: Incidence and current treatment strategies. Ann Surg. 2006;243:212-222. [PMID: 16432354 DOI: 10.1097/01.sla.0000197702.46394.16] [Cited by in Crossref: 346] [Cited by in F6Publishing: 306] [Article Influence: 21.6] [Reference Citation Analysis]
22 Kim SW. The result of conversion surgery in gastric cancer patients with peritoneal seeding. J Gastric Cancer 2014;14:266-70. [PMID: 25580359 DOI: 10.5230/jgc.2014.14.4.266] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
23 Sugarbaker PH. Second-look surgery for colorectal cancer: revised selection factors and new treatment options for greater success. Int J Surg Oncol. 2011;2011:915078. [PMID: 22312530 DOI: 10.1155/2011/915078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
24 Guerrero WL, Munene G, Dickson PV, Darby D, Davidoff AM, Martin MG, Glazer ES, Shibata D, Deneve JL. Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancy. J Gastrointest Oncol 2018;9:338-47. [PMID: 29755773 DOI: 10.21037/jgo.2018.01.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Qu ZB, Liu LX. Management of pseudomyxoma peritonei. World J Gastroenterol 2006; 12(38): 6124-6127 [PMID: 17036382 DOI: 10.3748/wjg.v12.i38.6124] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
26 McGee SF, AlGhareeb W, Ahmad CH, Armstrong D, Babak S, Berry S, Biagi J, Booth C, Bossé D, Champion P, Colwell B, Finn N, Goel R, Gray S, Green J, Harb M, Hyde A, Jeyakumar A, Jonker D, Kanagaratnam S, Kavan P, MacMillan A, Muinuddin A, Patil N, Porter G, Powell E, Ramjeesingh R, Raza M, Rorke S, Seal M, Servidio-Italiano F, Siddiqui J, Simms J, Smithson L, Snow S, St-Hilaire E, Stuckless T, Tate A, Tehfe M, Thirlwell M, Tsvetkova E, Valdes M, Vickers M, Virik K, Welch S, Marginean C, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference 2017. Curr Oncol 2018;25:262-74. [PMID: 30111967 DOI: 10.3747/co.25.4083] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Lansom J, Alzahrani N, Liauw W, Morris DL. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours. Indian J Surg Oncol 2016;7:166-76. [PMID: 27065707 DOI: 10.1007/s13193-015-0478-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
28 García KM, Flores KM, Ruiz A, González FL, Rodríguez ÁM. Pseudomyxoma Peritonei: Case Report and Literature Review. J Gastrointest Cancer 2019;50:1037-42. [PMID: 30618002 DOI: 10.1007/s12029-018-00192-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Moon J, Yoo YC, Kim MH, Jeon S, Joo HJ, Chun DH, Kim NY. Administration of Low-Dose Dexmedetomidine Did Not Affect Acute Inflammatory Response after Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy: A Double-Blind Randomized Controlled Trial. J Clin Med 2021;10:3145. [PMID: 34300310 DOI: 10.3390/jcm10143145] [Reference Citation Analysis]
30 Mistry P, Mohamed F, Dayal S, Cecil TD, Moran BJ. Cytoreductive surgery with intraperitoneal chemotherapy in the management of peritoneal surface malignancy: a pharmacist's perspective. Eur J Hosp Pharm 2016;23:233-8. [PMID: 31156855 DOI: 10.1136/ejhpharm-2016-000877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Santullo F, Pacelli F, Abatini C, Attalla El Halabieh M, Fortunato G, Lodoli C, Giovinazzo F, Rotolo S, Di Giorgio A. Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience. Front Surg 2021;8:715119. [PMID: 34513915 DOI: 10.3389/fsurg.2021.715119] [Reference Citation Analysis]
32 Carboni F, Federici O, Sperduti I, Zazza S, Sergi D, Corona F, Valle M. Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience. Cancers (Basel) 2021;13:523. [PMID: 33572964 DOI: 10.3390/cancers13030523] [Reference Citation Analysis]
33 Königsrainer I, Horvath P, Struller F, Königsrainer A, Beckert S. Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases. J Gastric Cancer. 2014;14:117-122. [PMID: 25061539 DOI: 10.5230/jgc.2014.14.2.117] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
34 Macrì A, Fortugno A, Saladino E. Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia. World J Gastrointest Oncol 2011; 3(12): 169-174 [PMID: 22224171 DOI: 10.4251/wjgo.v3.i12.169] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
35 Bae JM, Yeo KJ, Kim SW, Kim SW, Song SK. Clinical outcomes according to primary treatment in gastric cancer patients with peritoneal seeding. J Gastric Cancer 2011;11:167-72. [PMID: 22076222 DOI: 10.5230/jgc.2011.11.3.167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Macrì A, Accarpio F, Arcoraci V, Casella F, De Cian F, De Iaco P, Orsenigo E, Roviello F, Scambia G, Saladino E, Galati M. Predictors of morbidity and mortality in patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for ovarian carcinomatosis: a multicenter study. Pleura Peritoneum 2021;6:21-30. [PMID: 34222647 DOI: 10.1515/pp-2020-0139] [Reference Citation Analysis]
37 Van der Speeten K, Stuart OA, Sugarbaker PH. Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy. Curr Drug Discov Technol. 2009;6:72-81. [PMID: 19275544 DOI: 10.2174/157016309787581084] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
38 Low RN. Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. J Gastrointest Oncol 2016;7:58-71. [PMID: 26941984 DOI: 10.3978/j.issn.2078-6891.2015.115] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
39 Cistaro A, Cucinotta M, Cassalia L, Priola A, Priola S, Pappalardo M, Coppolino P, De Simone M, Quartuccio N. (18)F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic management in peritoneal carcinomatosis: A pilot study. Rev Esp Med Nucl Imagen Mol 2016;35:232-7. [PMID: 26907833 DOI: 10.1016/j.remn.2016.01.001] [Reference Citation Analysis]
40 Ben-Yaacov A, Nizri E, Lahat G, Berger Y, Sadot E, Lavi R, Zippel D, Sebbag G, Avital I, Hoffman A, Gutman M, Halevy A, Schneibaum S, Ben-Ari G, Benchimol D, Klausner J, Nissan A; Israeli Peritoneal Oncology Research Group. Treatment of Peritoneal Surface Malignancies with Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Experience in Israel. Indian J Surg Oncol 2019;10:19-23. [PMID: 30886488 DOI: 10.1007/s13193-019-00874-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Guerrero W, Munene G, Dickson PV, Stiles ZE, Mays J, Davidoff AM, Glazer ES, Shibata D, Deneve JL. Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis. J Gastrointest Oncol 2018;9:664-73. [PMID: 30151262 DOI: 10.21037/jgo.2018.04.05] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Lin YL, Xu DZ, Li XB, Yan FC, Xu HB, Peng Z, Li Y. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet J Rare Dis 2021;16:85. [PMID: 33581733 DOI: 10.1186/s13023-021-01723-6] [Reference Citation Analysis]